Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-057294
Filing Date
2025-06-06
Accepted
2025-06-06 16:01:49
Documents
20
Effectiveness Date
2025-06-06

Document Format Files

Seq Description Document Type Size
1 S-8 tm2517081d1_s8.htm S-8 58442
2 EXHIBIT 5.1 tm2517081d1_ex5-1.htm EX-5.1 12181
3 EXHIBIT 23.1 tm2517081d1_ex23-1.htm EX-23.1 2382
4 EXHIBIT 99.2 tm2517081d1_ex99-2.htm EX-99.2 25505
5 EXHIBIT 99.3 tm2517081d1_ex99-3.htm EX-99.3 39736
6 EXHIBIT 99.4 tm2517081d1_ex99-4.htm EX-99.4 40118
7 EXHIBIT 99.5 tm2517081d1_ex99-5.htm EX-99.5 37630
8 GRAPHIC tm2517081d_ex5-1img001.jpg GRAPHIC 4314
9 GRAPHIC tm2517081d1_ex5-1img01.jpg GRAPHIC 2822
10 EX-FILING FEES tm2517081d1_ex-filingfees.htm   iXBRL EX-FILING FEES 12697
  Complete submission text file 0001104659-25-057294.txt   355888

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2517081d1_ex-filingfees_htm.xml XML 4704
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287838 | Film No.: 251030442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)